Santhera Pharmaceuticals Holding AG (LON:0QN1)
London · Delayed Price · Currency is GBP · Price in CHF 16.25
+1.91 (13.29%)
Feb 12, 2026, 4:03 PM GMT
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 79 employees as of December 31, 2024. The number of employees increased by 34 or 75.22% compared to the previous year.
Employees
79
Change (1Y)
34
Growth (1Y)
75.22%
Revenue / Employee
569.45K GBP
Profits / Employee
-761.45K GBP
Market Cap
212.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 79 | 34 | 75.22% |
| Dec 31, 2023 | 45 | -1 | -2.18% |
| Dec 31, 2022 | 46 | 6 | 16.24% |
| Dec 31, 2021 | 39 | -47 | -54.19% |
| Dec 31, 2020 | 86 | -27 | -23.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Integrated Diagnostics Holdings | 6,309 |
| Tristel | 267 |
| Diaceutics | 213 |
| Animalcare Group | 201 |
Santhera Pharmaceuticals Holding AG News
- 4 weeks ago - Swissmedic Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy - Nasdaq
- 3 months ago - Half Year 2025 Santhera Pharmaceuticals Holding AG Analyst Briefing Transcript - GuruFocus
- 4 months ago - Santhera Partners With Biomedica To Distribute Agamree In Russia - Nasdaq
- 4 months ago - Health Canada Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy - Nasdaq
- 4 months ago - Santhera Pharmaceuticals Holding AG (SPHDF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Santhera Pharmaceuticals Holding AG 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 5 months ago - Santhera Pharma Stock Down On Wider H1 Loss; Is AGAMREE On Track? - Nasdaq
- 5 months ago - Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India - GlobeNewsWire